Ilan Green

1.9k total citations
53 papers, 1000 citations indexed

About

Ilan Green is a scholar working on Infectious Diseases, Rheumatology and Psychiatry and Mental health. According to data from OpenAlex, Ilan Green has authored 53 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Rheumatology and 9 papers in Psychiatry and Mental health. Recurrent topics in Ilan Green's work include COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Neonatal Health and Biochemistry (5 papers). Ilan Green is often cited by papers focused on COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Neonatal Health and Biochemistry (5 papers). Ilan Green collaborates with scholars based in Israel, United States and Georgia. Ilan Green's co-authors include Eugene Merzon, Shlomo Vinker, Avivit Golan‐Cohen, Eli Magen, Milana Frenkel‐Morgenstern, Alessandro Gorohovski, Dmitry Tworowski, Ariel Israel, Eytan Ruppin and Alejandro A. Schäffer and has published in prestigious journals such as Clinical Infectious Diseases, BMJ and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Ilan Green

44 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilan Green Israel 12 591 229 193 159 89 53 1000
Eugene Merzon Israel 15 613 1.0× 239 1.0× 206 1.1× 164 1.0× 103 1.2× 61 1.1k
Avivit Golan‐Cohen Israel 12 573 1.0× 224 1.0× 200 1.0× 124 0.8× 41 0.5× 58 938
Petre Cristian Ilie United Kingdom 9 430 0.7× 316 1.4× 299 1.5× 145 0.9× 47 0.5× 18 893
Abdullah Alqahtani Saudi Arabia 11 319 0.5× 35 0.2× 56 0.3× 226 1.4× 20 0.2× 68 916
George Alberti United Kingdom 10 394 0.7× 37 0.2× 90 0.5× 218 1.4× 22 0.2× 19 1.7k
Tiziana Ciarambino Italy 19 155 0.3× 39 0.2× 27 0.1× 100 0.6× 40 0.4× 65 945
Jonas Christoffer Lindstrøm Norway 19 103 0.2× 160 0.7× 43 0.2× 71 0.4× 90 1.0× 52 946
Nerys M. Astbury United Kingdom 21 235 0.4× 29 0.1× 165 0.9× 114 0.7× 14 0.2× 56 1.6k
Niklas Worm Andersson Denmark 15 186 0.3× 26 0.1× 32 0.2× 25 0.2× 41 0.5× 39 803
Michael S. Sherman United States 15 173 0.3× 51 0.2× 79 0.4× 345 2.2× 24 0.3× 45 1.1k

Countries citing papers authored by Ilan Green

Since Specialization
Citations

This map shows the geographic impact of Ilan Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Green more than expected).

Fields of papers citing papers by Ilan Green

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilan Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Green. The network helps show where Ilan Green may publish in the future.

Co-authorship network of co-authors of Ilan Green

This figure shows the co-authorship network connecting the top 25 collaborators of Ilan Green. A scholar is included among the top collaborators of Ilan Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilan Green. Ilan Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Magen, Eli, et al.. (2024). Increased Rates of Infectious Diseases in Fibromyalgia Patients: A Population-Based Case-Control Study. Biomedicines. 12(12). 2821–2821. 1 indexed citations
3.
Magen, Eli, et al.. (2024). Chronic idiopathic eosinopenia, allergic, and autoimmune disorders. The Journal of Allergy and Clinical Immunology In Practice. 12(7). 1933–1936.e1.
4.
Merzon, Eugene, Shai Ashkenazi, Eli Magen, et al.. (2024). Increased Prevalence of Attention Deficit Hyperactivity Disorder in Individuals with Selective Immunoglobulin A Deficiency: A Nationwide Case–Control Study. Journal of Clinical Medicine. 13(20). 6075–6075.
5.
6.
Rose, Adam J., Wiessam Abu Ahmad, Avivit Golan‐Cohen, et al.. (2023). Patient-level predictors of temporal regularity of primary care visits. BMC Health Services Research. 23(1). 456–456. 3 indexed citations
7.
Merzon, Eugene, Shai Ashkenazi, Shlomo Vinker, et al.. (2023). The Association between Previous Antibiotic Consumption and SARS-CoV-2 Infection: A Population-Based Case-Control Study. Antibiotics. 12(3). 587–587.
8.
Merzon, Eugene, Eli Magen, Shai Ashkenazi, et al.. (2023). The Association between Glucose 6-Phosphate Dehydrogenase Deficiency and Attention Deficit/Hyperactivity Disorder. Nutrients. 15(23). 4948–4948. 1 indexed citations
9.
Magen, Eli, Eugene Merzon, Ilan Green, et al.. (2023). Chronic idiopathic eosinopenia and chronic spontaneous urticaria. The Journal of Allergy and Clinical Immunology In Practice. 11(8). 2583–2586. 2 indexed citations
10.
Magen, Eli, Eugene Merzon, Ilan Green, et al.. (2023). Selective IgA deficiency and COVID-19. The Journal of Allergy and Clinical Immunology In Practice. 11(6). 1936–1938. 3 indexed citations
11.
Golan‐Cohen, Avivit, et al.. (2023). Biologic therapy is associated with malignancies among Israeli patients with rheumatoid arthritis: A population‐based study. International Journal of Rheumatic Diseases. 26(7). 1330–1336. 4 indexed citations
12.
Israel, Ariel, Shai Ashkenazi, Shlomo Vinker, et al.. (2023). The Association of Weight Reduction and Other Variables after Bariatric Surgery with the Likelihood of SARS-CoV-2 Infection. Journal of Clinical Medicine. 12(12). 4054–4054.
13.
Israel, Ariel, Alejandro A. Schäffer, Matitiahu Berkovitch, et al.. (2023). Glucose-6-phosphate dehydrogenase deficiency and long-term risk of immune-related disorders. Frontiers in Immunology. 14. 1232560–1232560. 10 indexed citations
14.
Israel, Ariel, Eugene Merzon, Yotam Shenhar, et al.. (2022). Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination. Vaccines. 10(5). 636–636. 1 indexed citations
15.
Israel, Ariel, Alejandro A. Schäffer, Eugene Merzon, et al.. (2022). A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received. Microorganisms. 10(6). 1238–1238. 2 indexed citations
16.
Merzon, Eugene, Ilan Green, Shlomo Vinker, et al.. (2021). The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection. FEBS Journal. 288(17). 5179–5189. 33 indexed citations
17.
Green, Ilan, Avivit Golan‐Cohen, Shlomo Vinker, et al.. (2021). Higher rates of allergies, autoimmune diseases and low-grade inflammation markers in treatment-resistant major depression. Brain Behavior & Immunity - Health. 16. 100313–100313. 15 indexed citations
18.
Israel, Ariel, Eugene Merzon, Alejandro A. Schäffer, et al.. (2021). Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study. BMJ. 375. e067873–e067873. 103 indexed citations
19.
Israel, Ariel, Yotam Shenhar, Ilan Green, et al.. (2021). Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection. Vaccines. 10(1). 64–64. 141 indexed citations
20.
Merzon, Eugene, Dmitry Tworowski, Alessandro Gorohovski, et al.. (2020). Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study. FEBS Journal. 287(17). 3693–3702. 296 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugene Merzon Breakdown of academic impact, for papers by Avivit Golan‐Cohen Breakdown of academic impact, for papers by Petre Cristian Ilie Breakdown of academic impact, for papers by Abdullah Alqahtani Breakdown of academic impact, for papers by George Alberti Breakdown of academic impact, for papers by Tiziana Ciarambino Breakdown of academic impact, for papers by Jonas Christoffer Lindstrøm Breakdown of academic impact, for papers by Nerys M. Astbury Breakdown of academic impact, for papers by Niklas Worm Andersson Breakdown of academic impact, for papers by Michael S. Sherman
Rankless by CCL
2026